Neurodevice Co SPR Therapeutics Raises Series A

Neurodevice firm SPR Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. The funds will be used to commercialize pain therapies using SPR’s proprietary peripheral nerve stimulation technology.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget